recent articles
Immunoscore® Is Now Available In Rectal Cancer
Immunoscore® is now available in Rectal Cancer for expert clinical centers through an Innovation Access Program Immunoscore® heads up to become the standard precision tool for the “Watch and Wait” strategy in locally...
HalioDx Part of the COLOSSUS Project to Improve Treatment for Color...
- Anatomic Pathology
- Clinical Laboratories
- Clinical Pathology
- Data Management
- Device Manufacturers
- Digital Pathology News
- Electronic Medical Records
- File format
- Image Analysis
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- New Digital Imaging Technologies
- Pathology News
- Storage
- Vendor products
- Whole slide
COLOSSUS aim is to better stratify metastatic colorectal patients for improving treatments The project gathers a large European consortium of leading cancer centers and private companies HalioDx is exploring immuno-oncology...
This funding will accelerate the development of Immunoscore® in selected cancers, and support set up of commercial activities in the US This round was led by PSIM fund managed by Bpifrance in the framework of the program ‘Investing...
HalioDx receives CLIA Compliance for its laboratory based in Marseille Immunoscore® Colon, is now available to US patients in selected states with a turnaround time of 10 days Marseille, June 21, 2017 - HalioDx announced today that...
Immunoscore® Colon is the first standardized immune‐based assay for the classification of cancers Immunoscore® has been validated by the Immunoscore® worldwide consortium, led by the SITC (ASCO 2016) Immunoscore® is a...
